Pyxis Oncology, Inc. — Director's Dealing 2024

Mar 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2024-03-26

Reporting Person: Sullivan Lara (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-26	Stock Option (Right to Buy)	$3.83	A	1071242	Acquired	2034-03-26	Common Stock (1071242)	Direct

Footnotes

F1: The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 26, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.